Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Janney Montgomery Scott Downgrades FB Financial to Neutral

Janney Montgomery Scott Downgrades FB Financial to Neutral

Janney Montgomery Scott analyst Feddie Stickland downgrades FB Financial (NYSE:FBK) from Buy to Neutral.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Janney Montgomery Scott analyst Feddie Stickland downgrades FB Financial (NYSE:FBK) from Buy to Neutral.

News

Why Tharimmune (THAR) Shares Are Getting Hammered

By Henry Khederian

June 10, 12:04 PM

Tharimmune shares are trading lower by 30% during Monday's session. The company late Friday announced it had entered into an "at the market" offering agreement.

THAR

Cocrystal Pharma Advances One Of Its COVID-19 Antiviral Treatment Candidate

By Vandana Singh

October 11, 11:51 AM

Cocrystal Pharma Inc (NASDAQ:COCP) selected CDI-988 for clinical development as an oral treatment for COVID-19. CDI-988 targeted a highly conserved…

COCP

B of A Securities Initiates Coverage On Marriott Vacations with Neutral Rating, Announces Price Target of $180

By Benzinga Newsdesk

February 6, 7:25 AM

B of A Securities analyst Shaun Kelley initiates coverage on Marriott Vacations (NYSE:VAC) with a Neutral rating and announces Price Target of $180.

VAC

New York Community Bancorp Q2 Earnings Beat Estimates Aided By Higher Interest Rate Environment

By Nabaparna Bhattacharya

July 27, 12:50 PM

New York Community Bancorp, Inc. (NYSE: NYCB) reported Q2 Net interest income of $900 million,

NYCB

Janney Montgomery Scott Downgrades FB Financial to Neutral

Related Posts

Why Tharimmune (THAR) Shares Are Getting Hammered

Cocrystal Pharma Advances One Of Its COVID-19 Antiviral Treatment Candidate

B of A Securities Initiates Coverage On Marriott Vacations with Neutral Rating, Announces Price Target of $180

New York Community Bancorp Q2 Earnings Beat Estimates Aided By Higher Interest Rate Environment